SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : dsco Discovery Laboratories

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (237)4/22/2009 10:42:28 AM
From: Arthur Radley   of 318
 
BJ...IMO the problem is that we are only getting Cappy's spin on this story. I find it hard to believe that the FDA would stop this drug from being approved when you consider the only option for an FDA approved drug. If the FDA has a drug approved that is made from 'mince meat' cow parts then impurity and consistency must be an issue that the FDA doesn't find a problem. However, it appears that DSCO "must" have a major problem with their manufacturing process.

Bottomline........DSCO management is spinning a one-sided response. DSCO needs a partnership deal.....and it appears obvious that they can't find such, as they would have to show any partner the full data on all aspects of Surfaxin.

I'm out of this stock and have no plans to buy back.......there is much need for this drug, but I don't think DSCO has the required resources, nor management savvy to get it done! All Just My Opinion!!!

Good luck..

Take a look at MITI news today......looks encouraging!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext